The cellular localization of GLUT3 messenger ribonucleic acid (mRNA) and protein was examined in human term placenta using a combination of methodologies. In situ hybridization indicated that GLUT3 mRNA was present in the trophoblast cell layer and in vascular endothelium with a heterogeneous distribution pattern. GLUT3 protein migrating at an apparent molecular mass of 49 kDa was detected by immunoblotting in membranes from whole placenta and endothelial cells derived from intraplacental microvessels, but not in isolated trophoblast cells. This cell-specific pattern of expression was confirmed by immunocytochemical studies showing a prominent localization of GLUT3 protein in vascular endothelium. These findings indicate a differential distribution of GLUT3 mRNA and protein in the human placenta. Based on its cell-specific distribution at the fetal interface, GLUT3 protein could be of cardinal importance in the transport of glucose from the placenta to the fetal circulation. (J Clin Endocrinol Metab 82: 2689 -2694, 1997 G LUCOSE TRANSPORT across the cell membrane is carried out along a concentration gradient by facilitative glucose transporters that belong to a family of structurally related membrane proteins. Seven genes have been identified and named GLUT1-7. They encode distinct proteins, with the exception of GLUT6, a pseudogene that is not expressed at the protein level (reviewed in Refs. 1 and 2). GLUT1-5 exhibit high sequence homology, but each isoform has a specific cellular distribution and level of expression (reviewed in Ref.
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carried out along a concentration gradient by facilitative glucose transporters that belong to a family of structurally related membrane proteins. Seven genes have been identified and named GLUT1-7. They encode distinct proteins, with the exception of GLUT6, a pseudogene that is not expressed at the protein level (reviewed in Refs. 1 and 2). GLUT1-5 exhibit high sequence homology, but each isoform has a specific cellular distribution and level of expression (reviewed in Ref. 3) . Two of these transporters, GLUT1 and GLUT3, are likely to play a significant role in the placenta, ensuring glucose uptake and transport function. GLUT1 is almost ubiquitously expressed (3, 4) , and GLUT3 is found in several tissues, with a predominant expression in the brain (5) (6) (7) .
Glucose is transferred across the placenta by facilitative diffusion through specific glucose transporter proteins (reviewed in Ref. 8) . GLUT1 is the main isoform expressed in mammalian placentas (9, 10) . It is found at high levels in human placenta throughout pregnancy (11) (12) (13) . By contrast, the localization and pattern of expression of GLUT3 have not been clearly defined. GLUT3 messenger ribonucleic acid (mRNA) has been found at high levels in both rodent (14, 15) and human (16) placentas. We have recently identified GLUT3 protein in the labyrinthine zone of the rat placenta (14) . In the human placenta, GLUT3 protein was either not detected (5, 12, 17) or was present at a low level (18) , leading to the hypothesis that GLUT3 mRNA would be present but not translated into a readily detectable protein.
The present study was undertaken to characterize the expression of GLUT3 glucose transporter in the human placenta. GLUT3 mRNA and protein were detected by in situ hybridization as well as by immunodetection studies and compared to GLUT1 levels in various human placental cell types.
Materials and Methods

Tissues, cells, and culture conditions
Freshly delivered human term placentas were aseptically collected after normal pregnancies (38 -40 weeks postmenstruation) after cesarean section or vaginal delivery. After removing the chorionic and basal plates, tissue samples (5 ϫ 5 mm) were excised within an intact placental lobule. Samples for immunohistochemistry and in situ hybridization were immediately fixed and processed as described in the relevant sections. Samples for immunoblotting and Northern blotting analysis were frozen in liquid nitrogen and stored at Ϫ80 C. The endothelial cells were prepared by a two-step collagenase-dispase and trypsin-deoxyribonuclease digestion of size-fractionated villi as previously described (19) . Eight days after plating, the confluent endothelial cells were dissociated with trypsin and resuspended in DMEM for subsequent primary cultures. Protein and RNA analyses were performed on cells obtained after the second passage. Cytotrophoblast cells were prepared from term human placenta by the technique of Kliman et al. (20) . After Percoll gradient, purified cytotrophoblasts (6 ϫ 10 6 cells) were used to prepare whole lysate, and the remaining cells were plated at a density of 2 ϫ 10 6 /35-mm well in DMEM supplemented with 20% heat-inactivated FCS and antibiotics. Syncytiotrophoblast cells were obtained after 48-h culture and further processed for immunoblot analysis. The characteristics of these cultured cells have been described previously (21) .
Antibodies and complementary DNA (cDNA) probes
The antibodies used were rabbit polyclonal antisera directed against the intracellular C-terminus of rat brain GLUT1 (amino acids 479 -492) purchased from East Acres Biologicals (Southbridge, MA) and to the C-terminal 14-amino acid sequence of human brain GLUT3 (amino acids 481-493), provided by Dr. G. W. Gould (University of Glasgow, Glasgow, Scotland). Antiactin antibody raised against the C-terminal 11 residues of actin, epitope conserved in all actin isoforms was purchased from Sigma Chemical Co. (St. Louis, MO). Human GLUT3 cDNA probe was prepared from a 2.6-kilobase (kb) SalI/BglI fragment subcloned into pBSK ϩ , and human GLUT1 cDNA was prepared from a 1.75-kb SalI fragment subcloned into pGEM4Z. Vectors were provided by Prof. G. I. Bell (University of Chicago, Chicago, IL). Rat ␤-actin cDNA probe was obtained as a 3.75-kb fragment subcloned into pBR322. Probes were labeled with [␣-32 P]deoxy-ATP using the multiprime labeling system (Amersham International, Aylesbury, UK). The peptide corresponding to the C-terminal 13 amino acids of the human GLUT3 sequence MN-SIEPAKETTTNV (16) was purchased from Neosystem (Strasbourg, France). Antisense synthetic 24-mer oligonucleotide specific for rat 18S ribosomal RNA was end labeled with [␥-32 P]ATP (Amersham International) using T4 polynucleotide kinase.
In situ hybridization
GLUT1 and GLUT3 cDNA probes were subcloned into PGEM-3Z vectors. Digoxigenin (DIG)-deoxy-UTP-labeled riboprobes were obtained using T7 and SP6 polymerases with an RNA labeling kit (Boehringer Mannheim, Germany). Sense probes were generated using restriction enzymes/RNA polymerases HindIII/SP6 for GLUT1 and HindIII/T7 for GLUT3, and antisense probes were generated using SacI/T7 for GLUT1 and SmaI/SP6 for GLUT3. Placental tissue samples (5 ϫ 5 mm) were fixed by immersion in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 3 h at 4 C, then soaked in increasing concentrations of saccharose (12%, 15%, and 18%). After embedding in Tissue-Tek (Miles, Naperville, IL) and freezing at Ϫ20 C, 5-m cryostat sections were mounted on aminopropyltriethoxysilane (Sigma Chemical Co.)-coated slides and kept at Ϫ80 C with dessicant. After thawing, the mounted sections were rehydrated and postfixed with 4% paraformaldehyde for 20 min, then treated for 10 min with 0.25% acetic anydride in 0.1 mol/L triethanolamine. Prehybridization was carried out for 2 h at 50 C in 50% formamide, 5 ϫ SSC (standard saline citrate), 5 ϫ Denhart's solution, 50 g/mL yeast transfer RNA, 250 g/mL salmon sperm DNA, 4 mmol/L ethylenediamine tetraacetate, and 2.5% dextran sulfate. Hybridization was carried out overnight at 50 C in a moist chamber using prehybridization buffer with sense or antisense RNA probes at concentrations of 1-2 ng/L for GLUT1 and 5-10 ng/L for GLUT3. Slides were washed with 50% formamide for 30 min in 2 ϫ SSC. They were then treated twice for 30 min at 37 C with ribonuclease A (20 mg/mL) in 10 mmol/L Tris buffer, pH 8, containing 0.5 mol/L NaCl and 10 mmol/L ethylenediamine tetraacetate. The final wash was performed at room temperature in 0.2 and 0.1 ϫ SSC. Slides were incubated for 30 min in 150 mmol/L NaCl and 100 mmol/L Tris-HCl, pH 7.5, containing 0.5% blocking agent (Boehringer Mannheim) and incubated overnight at room temperature with an alkaline phosphatase anti-DIG antibody diluted to 1:500 in the same buffer. After two 15-min washes in 150 mmol/L NaCl and 100 mmol/L Tris-HCl, pH 7.5, and a 3-min wash in 50 mmol/L MgCl 2 , 100 mmol/L NaCl and 100 mmol/L Tris-HCl, pH 9.5, sections were incubated for 2-3 h at 37 C with the substrates of alkaline phosphatase, 75 g/mL nitro blue tetrazolium, and 50 g/mL 5-bromo-4-chloro-3-indolyl-phosphate in the last wash containing 100 mmol/L levamisol (Boehringer). The reaction was stopped by rinsing with water, and slides were mounted in glycerol-gelatin.
Immunohistochemistry
Frozen cryostat sections (5 m) of paraformaldehyde-fixed placental tissue were used for indirect immunofluorescence with anti-GLUT3 and anti-GLUT1 antibodies diluted 1:250 and 1:5000, respectively. Sections were air-dried, fixed in 2.5% paraformaldehyde for 20 min, washed in PBS, and incubated with 1% normal goat serum for 1 h to reduce nonspecific binding. After an overnight incubation at 4 C with 20 L primary antibodies diluted in PBS containing 1% normal goat serum, sections were washed for 10 min with PBS. Incubation with the secondary antibody, fluorescein isothiocyanate-conjugated goat antirabbit IgG (Pasteur-Sanofi, Marnes-la-Coquette, France) at a 1:500 dilution was carried out in the dark for 1 h at 23 C. Sections were then washed for 30 min in PBS and mounted in mowiol (Sigma). Some sections were treated with 500 nmol/L tetramethylrhodamine B isothiocyanate-labeled phalloidin (Sigma) for 10 min, followed by three 10 min-PBS washes before incubation with primary antibody to visualize actin filaments. Controls were performed by omitting primary antibodies. For competition studies, the anti-GLUT3 antibody was preadsorbed with a peptide corresponding to the 13 C-terminal amino acids of human GLUT3, and all subsequent steps were carried out as described above.
RNA analysis
Total RNA was extracted from cultured cells according to Chomczynski's procedure (22) and from whole placenta according to Chirgwin's procedure (23) . The RNA concentration was determined by measuring absorbance at 260 nm, and Northern blotting was performed as previously described (14) . An antisense synthetic oligonucleotide (24-mer) specific for the 18S ribosomal subunit (24) was used to normalize for the relative differences in the amounts of RNA transferred to the filters. Quantitation of the signals was performed by scanning densitometry of the autoradiograms using a scanning analysis software (Scan Analysis, Biosoft, Cambridge, UK).
Membrane preparations
Placental membranes derived from four tissue fragments (1.5 g total wet weight) were obtained after differential centrifugations as described previously (14) . Endothelial and syncytiotrophoblast cells were rinsed twice with ice-cold PBS, then directly scraped in 2 ϫ electrophoresis sample buffer (Laemmli) containing 100 mmol/L dithiothreitol and sonicated for three 30-s periods at half-maximal speed (Sonics and Materials, Danbury, CT). Isolated cytotrophoblast cell pellets were lysed in 2 ϫ electrophoresis sample buffer. Protein contents were measured using the standard Bio-Rad (Richmond, CA) and Pierce-BCA (Pierce Chemical Co., Rockford, IL) assays.
Immunoblotting
Samples containing equal amounts of membrane proteins solubilized in 2 ϫ Laemmli buffer were applied to 10% SDS-polyacrylamide gels P-labeled human GLUT3, GLUT1, and nonmuscle ␤-actin cDNA probes were successively hybridized to the same blot. Autoradiograms are representative of three independent blots, and signals were quantitated by scanning densitometry. E, Endothelial cells from placental microvessels; P, whole placental tissue.
without heating and electrophoresed according to Laemmli (25) . After electrophoresis, proteins were transferred electrically as described previously (14) . Primary antibodies were used at 1:200 dilution for anti-GLUT3 and at 1:500 for anti-GLUT1 and anti-actin. The secondary antibody was a horseradish peroxidase-conjugated antirabbit IgG diluted 1:5000 (Amersham International). The immunoreactive signals were visualized by addition of ECL chemiluminescence reagent (Amersham International) according to the manufacturer's instructions.
Results
Glucose transporter and actin mRNA in placenta and vascular endothelial cells
Northern blot analysis. Concentrations of GLUT3 mRNA were compared to GLUT1 and nonmuscle ␤-actin in whole placental tissue and in endothelial cells from intraplacental microvessels (Fig. 1) . Two GLUT3 transcripts of 4.1 and 2.7 kb were detected in whole placenta and endothelial cells as previously reported for other human tissues, but the smaller 2.7-kb transcript that is known to be generated by alternative polyadenylation within the 3Ј-untranslated region (16) was predominantly expressed in endothelial cells. Similar levels of the 4.1-kb GLUT3 mRNA were found in placenta and endothelial cells (37 Ϯ 8 vs. 44 Ϯ 2 arbitrary densitometry units). GLUT1 mRNA, appearing as a single 2.8-kb transcript, was strongly expressed in placenta and to a lesser extent in endothelial cells from microvessels (234 Ϯ 11 vs. 20 Ϯ 1 arbitrary densitometry units). By contrast, the concentration of nonmuscle ␤-actin mRNA was 5-fold higher in endothelial cells than in whole placenta (Fig. 1) .
In situ hybridization. GLUT3 mRNA distribution was studied in sections of term placentas with an antisense RNA probe (Fig. 2) . Intense labeling was observed in the trophoblast cells surrounding some terminal villi, whereas adjacent villi of the same size remained unlabeled ( Fig. 2A) . A discontinuous distribution of GLUT3 mRNA was observed in the trophoblast cell layer of intermediate villi (Fig. 2B) . Stromal cells of intermediate and terminal villi were weakly stained with the GLUT3 probe, but cells from the vascular media did not show staining (Fig. 2, A-C) . Positive signal was also detected in vascular endothelium of intermediate villi (Fig. 2C) . No GLUT3 labeling was observed in placental sections incubated with a specific sense probe (Fig. 2D) .
The overall cellular localization of GLUT1 mRNA was similar to that of GLUT3 (Fig. 2, E-H) . However, the signal appeared much stronger and evenly distributed in trophoblast cells of all types of villi (Fig. 2, E-H) . Endothelium of intraplacental vessels were clearly stained, but at a lower intensity than the trophoblast cell layer (Fig. 2, F-H) . In addition, stromal cells regardless of the villous type and smooth muscle cells in the vascular media were also lightly stained with the GLUT1 RNA probe (Fig. 2, G and H) .
Immunological characterization of GLUT3 protein in human term placenta
A single prominent 49-kDa protein was detected in membrane fractions from human term placenta using anti-GLUT3 antibody (Fig. 3, lanes 1 and 2) , and no cross-reactivity was observed with purified actin from rabbit muscle (Fig. 3, lane  3) . By contrast, an antiactin antibody detecting all actin isoforms recognized a 42.7-kDa band in both placental membranes (Fig. 3, lanes 4 and 5) and in a purified actin sample (Fig. 3, lane 6) . A protein of higher molecular mass (ϳ90 kDa) was also identified in the placenta with the antiactin antibody (lanes 4 and 5). These results indicate that GLUT3 protein is present in term placenta and cannot be mistaken for actin, which migrates at a lower molecular mass.
Distribution of GLUT3 and GLUT1 proteins in placenta and microvascular endothelial cells
Immunocytochemical analysis. GLUT3 immunoreactivity (green staining) was found almost exclusively in the endothelium of fetal vessels of intermediate villi (Fig. 4B) . The fluorescent staining was efficiently competed by preincubation with human GLUT3 peptide (Fig. 4C) . Endothelial localization was confirmed by immunostaining of an adjacent section with anti-CD31 and anti-von Willebrand factor antibodies (not shown), two specific markers of endothelial cells (19) . Less intense staining intensity was noticed in stromal cells of intermediate villi, whereas yellow fluorescence was observed in the trophoblast layer regardless of the villous type (Fig. 4, A and B) . The yellow staining detected in   FIG. 3 . Immunoblot analysis of GLUT3 protein in human term placenta. Seventy-five micrograms of placental membrane (P) and 10 g purified rabbit actin (A) were subjected to SDS-PAGE and transferred onto nitrocellulose filters. The autoradiograms are representative of three separate experiments. P, placental membranes; A, actin. The positions of the molecular mass markers are indicated in kilodaltons. The entire running gel is shown. the trophoblast appeared as a reaction due to binding of the secondary antibody, as control sections showed the same coloration (Fig. 4C) . By contrast, strong GLUT1 immunoreactivity was found in the trophoblast layer of terminal and intermediate villi (Fig. 5, A and B) . Endothelium of fetal vessels as well as fetal erythrocytes were also immunopositive for GLUT1 (Fig. 5B) . Phalloidin, which visualizes actin filaments, counterstained both vascular media and perivascular myofibroblasts (Fig. 5C) .
Western blot analysis. The cell-specific localization of GLUT3 protein was further confirmed by immunoblotting experiments. Endothelial cells from intraplacental microvessels expressed GLUT3 protein (Fig. 6, lane 4) , although to a lesser extent than membranes derived from whole placenta (Fig. 6 , lane 1). GLUT3 protein had a higher apparent molecular mass in endothelial cells than in placental membranes (ϳ52 vs. 49 kDa), suggesting that GLUT3 is differently glycosylated in the two fractions. As expected, GLUT3 protein was not detected in isolated cytotrophoblast cells and differentiated syncytiotrophoblast cells (Fig. 6, lanes 2 and 3) .
Discussion
Although it has been accepted for several years that GLUT1 and GLUT3 are the two major placental glucose transporters, the presence of GLUT3 was not clearly established in the human placenta. Immunodetection studies using either purified membranes (5) or postnuclear and syncytiotrophoblast membranes from term placenta (12, 17) failed to detect significant amounts of GLUT3 protein, although one report suggested a faint protein expression in whole placental homogenate (18) . Thus, evidence for the presence of GLUT3 in human placenta rested mainly on the detection of mRNA transcripts in one tissue sample (16) . The present results clearly establish the presence of GLUT3 protein in human term placenta. Western blot analysis using anti-GLUT3 and antiactin antibodies show that GLUT3 protein cannot be mistaken for actin because the two proteins migrate at different apparent molecular masses of 49 and 42.7 kDa, respectively. Further, the anti-GLUT3 antibody used in the present study including immunocytochemistry did not cross-react with actin at all. These findings allowed us to obviate the potential pitfall of detecting actin instead of GLUT3 protein in immunolocalization studies (18) . The immunocytochemical localization of GLUT3 protein in endothelial cells was supported by the results obtained with Western blot analysis showing a GLUT3 signal in both whole placental membranes and endothelial cells from intraplacental microvessels. The presence of GLUT3 in vascular endothelium is not a specific feature of the placenta, as it has also been reported in human retinal endothelial cells (26) and at a lesser extent in microvessels of adult human brain (27) .
GLUT3 mRNA exhibited a trophoblastic localization re- (28) . The heterogeneity of GLUT3 mRNA expression that we observed among villi of the same size cannot be related to any obvious structural or functional specificity at present. Because a heterogeneous pattern of staining was observed in sections derived from four placentas, we believe that in normal term pregnancies, GLUT3 is present in certain villi but not in others. From a metabolic standpoint, this result could reflect regional responses to different stimuli, as GLUT3 mRNA expression has been shown to be regulated under various metabolic and hormonal conditions including hyperglycemia, hypoxia, and cellular stress (14, 29, 30) . A developmental regulation of GLUT3, decreasing as a function of gestational age (13) could also contribute to some extent to the heterogeneous mRNA distribution in term villi.
The discrepancy between GLUT3 mRNA and protein localization observed in the human placenta has been previously reported in other human tissues (5, 16, 27) . The reason for these differences is not yet elucidated, but these findings indicate that the mRNA level cannot be taken as an index of the protein concentration. It could explain that GLUT3 protein was not detected in human placenta using membrane fractions of syncytial origin (5, 12, 17) that express GLUT3 mRNA but do not contain GLUT3 protein. Alternatively, this difference might result from an instability of GLUT3 transcripts or a block of the translation of GLUT3 mRNA as previously speculated (5) and could also reflect the heterogeneous mRNA distribution observed by in situ hybridization.
The present study demonstrates that in the human placenta, GLUT3 protein is predominantly localized around fetal vessels. By contrast, GLUT1 is found in cells surrounding both maternal and fetal blood. Based on the higher affinity for glucose of human GLUT3 (K m ϭ ϳ1 mmol/L) compared to GLUT1 (K m ϭ ϳ5 mmol/L), one may speculate that the two isoforms will serve specific functions within the placenta. The regional distribution of GLUT3 at the fetal interface may ensure constant delivery of glucose to the fetal circulation even under conditions of low maternal blood glucose concentrations. Such a vectorial flow of glucose has been suggested to occur in neurons where GLUT3 is predominantly localized (31) . Besides placenta and brain, GLUT3 protein is also strongly expressed in testis (7) and may provide a high affinity transport system in tissues that should be protected from fuel deprivation.
